Back to Results
First PageMeta Content
Selective serotonin reuptake inhibitors / Medicine / Nitriles / Amines / Escitalopram / Citalopram / Serotonin–norepinephrine reuptake inhibitor / Antidepressant / Pimozide / Chemistry / Organic chemistry / Organofluorides


Lexapro (escitalopram oxalate) Tablets/Oral Solution NDA[removed]NDA[removed]Proposed Labeling Text Lexapro®
Add to Reading List

Document Date: 2009-03-31 14:51:03


Open Document

File Size: 208,64 KB

Share Result on Facebook

Company

Case / /

Event

Product Issues / /

IndustryTerm

isotonic saline solution / treatment of Generalized Anxiety Disorder / treatment for major depressive disorder / food / treatment of major depressive disorder / /

MedicalCondition

incoordination / insomnia / epistaxis / panic attacks / major depressive disorder / myoclonus / hyperreflexia / petechiae / obsessive compulsive disorder / headache / bipolar depression / psychomotor restlessness / shock / coma / hallucinations / nausea / mania / hypersomnia / psychomotor agitation / major depressive disorders / lethargy / Anxiety Disorder / vomiting / certain other psychiatric disorders / psychiatric disorders / fatigue / tachycardia / delirium / hypersensitivity / neuroleptic malignant syndrome / diarrhea / restlessness / dizziness / muscle rigidity / Depression / paresthesias / Generalized Anxiety Disorder / Syndrome / Bipolar Disorder / disorders / akathisia / /

MedicalTreatment

antidepressant therapy / drug therapy / /

Organization

DOSAGE AND ADMINISTRATION / /

Person

Depressive Disorder Lexapro / /

Position

physician / Major / General / /

Product

talc / Celexa / Escitalopram / Lexapro / linezolid / polyethylene glycol / sorbitol / escitalopram oxalate / dimethyl sulfoxide / patients / /

Technology

alpha / Pharmacokinetics / Pharmacodynamics / /

SocialTag